Kulsoom, B. et al. 2025. High-dose versus Standard-dose Daunorubicin in Induction Chemotherapy for Acute Myeloid Leukemia: A Meta-Analysis: High- vs Standard-Dose Daunorubicin in AML Induction Therapy. Journal of University College of Medicine and Dentistry. 4, 2 (Jun. 2025), 183–188. DOI:https://doi.org/10.51846/jucmd.v4i2.3972.